WK692
WK692 is a BCL6 inhibitor that inhibits the BCL6BTB/SMRT interaction. WK692 can effectively inhibit the growth of diffuse large B-cell lymphoma cells and synergize with EZH2 and PRMT5 inhibitors.[1].
Product Specifications
CAS Number
2694055-38-2
UNSPSC
12352005
Target
BCL6
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/wk692.html
Smiles
CN1C(C(OCCNC(CBr)=O)=CC2=CC(NC3=CC(N4CCC[C@@H]4COC(CBr)=O)=NC5=NC=NN35)=CC=C21)=O
Molecular Formula
C26H28Br2N8O5
Molecular Weight
692.36
References & Citations
[1]Xing Y, et al. A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma[J]. Molecular Cancer Therapeutics, 2024: OF1-OF12.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog